Data:2009-12-12 2:34
Category: Money Tips Date: 2007-07-23
Dashiyanpan:
Friday continued a recent trend in the Shanghai and Shenzhen tape re-opened slightly lower, followed by a day to maintain the basic test a low slightly after the narrow rocky for a total turnover of 14 billion yuan between the two cities. Message level, the SSE deputy general manager Zhou pointed out that the share reform the industry is expected to be completed within the next year basically; IPO and refinancing floodgates need two conditions, one market is stable, the second is the completion of reform of the company's stock market value of more than 50% of the total market capitalization.
Disk point of view, Wuhan Iron and Steel warrants are still limit-out, but the Wuhan Iron and Steel put warrants have occurred in heavy volume shocks, Baoshan Iron and Steel also warrants a certain degree of decline. The remaining stocks, the only part of the paper stocks rebounded relatively well, others such as finance, aviation, G Unit, and so their performance is acceptable plates, steel plates, after rising for two days down as well, while the blue chip share index remained stable order situation. Overall, the market tested the bottom last week after the rebound in stocks intraday once active, but the apparent lack of continuity, turnover has not shown any amplification, indicating the market still being in Ruoshi. As the trend warrants the continued hot, resulting in the two cities share the basic no one is interested, Friday G Wuhan Iron and Steel warrants daily limit and was re-opened large single-sealed, and put warrants was as high as 1.8 yuan, due to the creation of mechanisms for Monday imminent start Put Warrants will be faced with infinite supply, investors should face possible risks warrant.
Stock Recommendation: Huayuan Pharmaceutical (600,656) company's main business of proprietary Chinese medicines (including Chinese medicine and dried white fungus), chemical raw materials and preparations, antibiotics, biochemical medicines. Company is the world's largest manufacturers of vitamin C, vitamin C in China's four major export companies ranked second, leading prominent position. Secondary market perspective, the shock poised fully compare the short-term adjustment in place, the current stock price is absolutely low, only 2 yuan more than the development of promising, there are still up space, worthy of investor attention.
